Patent · US Active

Cancer immunotherapy using virus particles

US11590183B2 · kind B2 · utility

0Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 12, 2018
Grant dateFeb 28, 2023
Priority date
Expiry dateMar 6, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/40034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating cancer in a subject in need thereof includes administering in situ to the cancer a therapeutically effective amount of a virus or virus-like particle.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.